• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 180NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 180NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 0500318E
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Itching Sensation (1943)
Event Date 03/22/2017
Event Type  Injury  
Manufacturer Narrative
The clinical investigation and plant investigation are in process.A supplemental mdr will be submitted upon completion of these activities.
 
Event Description
A user facility nurse reported that a patient complained of pruritis (itching) during hemodialysis (hd) therapy with the fresenius optiflux 180nre dialyzer, despite a full recirculation of normal saline (nacl) and one full liter of normal saline flushed through the dialyzer prior to the treatment.Follow-up medical treatment information was provided, which confirmed that the patient was administered benadryl (diphenhydramine) 25 mg intravenously (iv).The treatment information also reported that the patient complained of cramps in which the ultrafiltration (uf) rate was turned off and the patient was administered 50 ml of nacl with effect.The patient completed the scheduled hd treatment and was discharged to home in stable condition.No malfunction of the fresenius dialyzer in use during the hd treatment was alleged, observed, or identified prior to, during, or following the event.The complaint device has not been returned to the manufacturer for evaluation.
 
Manufacturer Narrative
The information supports a temporal association between the optiflux dialyzer and the reported itching.However, there is no documentation to support a causal relationship between the itching and the optiflux dialyzer.The use of the optiflux dialyzer (polysulfone membrane, electron beam sterilization) was changed to the baxter exeltra 150 (cellulose triacetate membrane, gamma irradiation sterilization), and the itching had reoccurred.Also, the patient was administered heparin during hemodialysis (hd) treatment.It is unknown if there is a potential heparin allergy.A temporal association with the fresenius 2008k hd machine and cramping during hd treatment exists; however, this only led to temporary discomfort, the patient was given 50ml normal saline, and the ultrafiltration rate was turned off.There was no allegation of product malfunction.The patient was discharged to home in stable condition and returned for the next scheduled hd treatment.The patient has continued with hd therapy for renal replacement therapy.Plant investigation: the device was not returned to the manufacturer and the lot was not provided.A definitive conclusion regarding the complaint cannot be reached without physical examination of the complaint device.A records review was conducted on 14 lots of fresenius dialyzers (catalog 0500318e) identified to have been shipped to this account from 6/30/2016 to 5/1/2017.Three lots were identified with one approved temporary deviation notice per lot and one lot was identified with one material containment hold; the lot was subsequently released.There was no non-conformance, deviation, rework, or process control issues which could be associated with the reported event.The records review did not reveal a probable cause for the complaint.Additionally, the dialyzer instructions for use (ifu) is included in each case of fresenius dialyzer product and cautions the user regarding reactions.
 
Event Description
Follow-up information with the patient¿s nurse revealed that the patient has regularly high potassium levels which is attributed to the patient¿s dietary intake.The patient has been repeatedly counseled on diet but continues to be non-compliant leading to the elevation of blood potassium level.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 180NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
475 west 13th street
ogden UT 84404
Manufacturer Contact
thomas c. johnson
920 winter st.
waltham, MA 02451
7816999499
MDR Report Key6645594
MDR Text Key77703058
Report Number1713747-2017-00204
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100156
UDI-Public00840861100156
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K002761
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 07/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/15/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number0500318E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Date Manufacturer Received06/16/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
Patient Weight69
-
-